← Back to Screener
Harvard Bioscience Inc (HBIO)
Price$6.40
Value ScoreA
Growth ScoreF
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-11.30%
Price vs S&P 500 (4W)-12.52%
VGM Score51.30
Market Capitalization$26.52M
All Metrics
P/CF (Annual)3.94x
Book Value / Share (Quarterly)$2.23
P/TBV (Annual)4.89x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-8.59%
Cash Flow / Share (Quarterly)$0.28
Price vs S&P 500 (YTD)-23.04%
Gross Margin (TTM)58.42%
Net Profit Margin (TTM)-11.44%
EPS (TTM)$-2.20
10-Day Avg Trading Volume0.03M
EPS Excl Extra (TTM)$-2.20
Revenue Growth (5Y)-3.25%
EPS (Annual)$-12.77
ROI (Annual)-114.31%
Gross Margin (Annual)57.67%
Net Profit Margin (5Y Avg)-18.07%
Cash / Share (Quarterly)$1.57
Revenue Growth QoQ (YoY)-4.68%
ROA (Last FY)-70.81%
Revenue Growth TTM (YoY)-6.42%
EBITD / Share (TTM)$0.53
ROE (5Y Avg)-90.12%
Operating Margin (TTM)-1.54%
Cash Flow / Share (Annual)$1.09
P/B Ratio2.64x
P/B Ratio (Quarterly)2.17x
Net Income / Employee (Annual)$-179,400
EV / Revenue (TTM)0.65x
Net Interest Coverage (TTM)-10.67x
ROA (TTM)-12.38%
EV / EBITDA (TTM)23.49x
EPS Incl Extra (Annual)$-12.77
Current Ratio (Annual)2.20x
Quick Ratio (Quarterly)1.06x
3-Month Avg Trading Volume0.05M
52-Week Price Return-12.24%
EV / Free Cash Flow (Annual)11.43x
Revenue / Employee (TTM)$270,700
Tangible BV / Share (Quarterly)$0.70
P/S Ratio (Annual)0.31x
Asset Turnover (Annual)1.08x
52-Week High$9.46
Operating Margin (5Y Avg)-13.36%
EPS Excl Extra (Annual)$-12.77
CapEx CAGR (5Y)10.13%
Tangible BV CAGR (5Y)-32.50%
26-Week Price Return4.63%
Quick Ratio (Annual)1.25x
13-Week Price Return-2.16%
Total Debt / Equity (Annual)2.61x
Current Ratio (Quarterly)1.99x
Enterprise Value$55.63M
Revenue / Share Growth (5Y)49.11%
Asset Turnover (TTM)1.08x
Book Value / Share Growth (5Y)9.55%
Revenue / Employee (Annual)$273,900
Inventory Turnover (Annual)1.66x
Pretax Margin (Annual)-66.30%
Cash / Share (Annual)$1.93
3-Month Return Std Dev101.00%
Gross Margin (5Y Avg)57.39%
Net Income / Employee (TTM)$-31,000
EBITDA Interim CAGR (5Y)-71.12%
ROE (Last FY)-412.84%
Net Interest Coverage (Annual)-0.69x
EPS Basic Excl Extra (Annual)$-12.77
P/FCF (TTM)3.89x
Receivables Turnover (TTM)6.10x
EV / Free Cash Flow (TTM)43.43x
Total Debt / Equity (Quarterly)3.60x
EPS Incl Extra (TTM)$-2.20
Receivables Turnover (Annual)5.60x
ROI (TTM)-20.12%
P/S Ratio (TTM)0.31x
Pretax Margin (5Y Avg)-17.83%
Revenue / Share (Annual)$19.50
Tangible BV / Share (Annual)$1.36
Forward P/E24.70x
Free OCF CAGR (5Y)-9.87%
Price vs S&P 500 (52W)-40.44%
Year-to-Date Return-12.11%
5-Day Price Return5.19%
EPS Normalized (Annual)$-12.77
ROA (5Y Avg)-17.96%
Net Profit Margin (Annual)-65.51%
Month-to-Date Return-7.84%
Cash Flow / Share (TTM)$0.09
EBITD / Share (Annual)$-10.31
Operating Margin (Annual)-57.55%
LT Debt / Equity (Annual)2.61x
P/CF (TTM)8.61x
ROI (5Y Avg)-27.60%
LT Debt / Equity (Quarterly)3.60x
EPS Basic Excl Extra (TTM)$-2.20
P/TBV (Quarterly)6.94x
P/B Ratio (Annual)2.17x
Inventory Turnover (TTM)1.58x
Pretax Margin (TTM)-11.57%
Book Value / Share (Annual)$3.07
Price vs S&P 500 (13W)-11.91%
Beta1.50x
P/FCF (Annual)5.45x
Revenue / Share (TTM)$19.12
ROE (TTM)-73.04%
52-Week Low$3.10
vGradeA
gGradeF
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.33est. -0.63
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.00
4.00
4.00
4.00
Industry Peers — Lab Analytical Instruments(24)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
HBIOHarvard Bioscience Inc | A | F | C | $6.40 |
| AAgilent Technologies Inc. | C | C | B | $135.98 |
| WATWaters Corp | D | C | B | $378.16 |
| ILMNIllumina Inc | D | D | A | $164.40 |
| MTDMettler-Toledo International | D | C | C | $1183.57 |
| RVTYRevvity, Inc. | C | D | B | $100.52 |
| BRKRBruker Corporation | D | D | A | $58.44 |
| BIOBio-Rad Laboratories, Inc.Class A | C | F | B | $305.46 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | F | B | $304.15 |
| AVTRAvantor, Inc. | B | D | C | $9.19 |
| TXG10x Genomics, Inc. Class A Common Stock | D | C | A | $29.59 |
About
Harvard Bioscience designs and manufactures specialized instruments and products for life sciences research, pharmaceutical discovery, and drug development. The company serves customers globally through direct and distribution channels, with brands including Harvard Apparatus, DSI, Buxco, Biochrom, and others. Most revenue is generated in the United States, though the company maintains operations across North America, Europe, and China.